Crossmark

CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients

Crossref DOI link: https://doi.org/10.1038/bjc.2017.173

Published Online: 2017-06-20

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barrera, Lourdes

Montes-Servín, Edgar

Hernandez-Martinez, Juan-Manuel

García-Vicente, María de los Ángeles

Montes-Servín, Elizabeth

Herrera-Martínez, Marytere

Crispín, José C

Borbolla-Escoboza, José Rafael

Arrieta, Oscar
License Information

Text and Data Mining valid from 2017-06-20
More Information

Article History

Received: 3 April 2017

Revised: 18 April 2017

Accepted: 19 May 2017

First Online: 20 June 2017

Competing interests

: José Rafael Borbolla-Escoboza is a full time AstraZeneca employee (Oncology Medical Affairs); Lourdes Barrera is a full time AstraZeneca employee (Oncology GPPS). However, the authors declare no conflict of interests since no AstraZeneca or competitor molecules were tested. The remaining authors declare no conflict of interests.